The city of Austin's Economic Development Department announced last week that pharmaceutical giant Merck & Co. Inc. has shown interest in building an information technology center in Austin. Here are 10 things to know about Merck and its plans in Austin:
1. Merck develops medicines and vaccines. It also conducts medical research into various diseases, including cancer, hepatitis C, cardio-metabolic disease, antibiotic-resistant infections and Alzheimer’s disease, as well as global pandemic diseases, such as ebola, according to the company. Merck is based in Kenilworth, New Jersey, and has about 68,000 employees worldwide.
2. The company wants to open an information technology “hub” in Austin. Merck began opening IT hubs in 2014 in order to centralize its IT staff. The company has opened hubs in Branchburg, New Jersey; Prague, Czech Republic; and Singapore.
3. No deal has been made. Pending approval of an economic development agreement between Austin City Council and Merck, the company anticipates it could open this year in a temporary location. Construction of a long-term space, proposed to be up to 90,000 square feet in size, could begin toward the end of 2018 and be completed by 2020, according to Merck.
4. Merck says it could bring 600 new jobs to Austin, according to a proposed performance-based agreement between the company and the city. The average annual salary for Merck's proposed Austin center is projected at $84,586, with the lowest 10 percent of employees earning an average of $54,511 annually. By 2026, the company projects its median annual salary for Austin-area employees would be $79,500.









